Tuberculosis

MEASURE Evaluation achievements in support of the STOP TB Strategy include supporting global standards for tuberculosis monitoring and evaluation; capacity building and technical assistance; development of TB tools and supporting country TB information systems; and evaluation/research.

Although tuberculosis (TB) is curable, it has devastating consequences on public health worldwide, second only to HIV in the number of deaths from infectious disease. In the most recent statistics available, the World Health Organization (WHO) has estimated that nine million people developed TB in 2013 and 1.5 million died of TB-related causes. They also estimated that of the nine million people with TB, three million were either not diagnosed, or were diagnosed but not reported to the national TB program, and 1.1 million of them were co-infected with HIV. Testing for HIV is critical to identify and treat co-infected people. However, in 2013 less than half of TB patients had a documented HIV test result. Multidrug-resistant TB (MDR-TB) affected an estimated 300,000 people in 2013, but only 136,000 were diagnosed and reported.

The WHO has a goal for an end to the global TB epidemic by 2035. In order to reach the ultimate goal of eliminating TB, efforts must be intensified and successes sustained through sufficient funding. To help determine the impact of these interventions, MEASURE Evaluation assists to develop monitoring and evaluation (M&E) standards and tools for national TB program surveillance systems to generate high-quality data for monitoring impact. As data from direct measurements within countries expand and improve, the estimates of TB burden can be refined to better track progress toward meeting the new targets set by WHO. 

MEASURE Evaluation also supports USAID’s commitment to the implementation of its STOP TB Strategy to reduce morbidity and mortality associated with TB, and in particular to strengthen TB information systems. MEASURE Evaluation partners with WHO, USAID, and additional key stakeholders, such as the Global Fund and others, to develop and implement global standards and tools, as well as to strengthen technical and organizational M&E capacity of TB programs, ministries of health and local NGOs at national and sub-national levels in various countries.

MEASURE Evaluation applies a systems approach to this important work by:

  • Strengthening TB information systems, one of the key components of the directly observed treatment, short course (DOTS) approach;
  • Establishing and supporting global standards for TB M&E;
  • Building both technical and organizational M&E capacity of TB organizations;
  • Improving the quality, coverage, timeliness, and sustainability of TB information systems;
  • Conducting TB evaluation/research. 

Related Content

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs
M&E of Tuberculosis Control Programs Module
Three Interlinked Patient Monitoring Systems for HIV care/ART, MCH/PMTCT and TB/HIV
Strengthening Tuberculosis Control in Ukraine: Impact Evaluation Baseline Survey, Ukraine 2014 
Infectious Diseases Tools

Filed under: